Stem cells play a unique role in helping the body repair itself. Because of this, consumers spend millions of dollars on stem cell treatments intended to increase the amount of active, adult stem cells in the body.
Autologous vs. Allogeneic
Autologous vs. Allogeneic are two common types of stem cell treatments. Both require the harvesting, concentration, and activation of the cells. In allogeneic treatments, the patient receives stem cells from someone other than themselves. While this process has shown benefits, the rejection of someone else’s genetic material by the patient’s body has sometimes resulted in dangerous side effects and even death. In autologous treatments, the patient’s own stem cells are reintroduced into their own body. Because the person is receiving their own genetic material the risk is dramatically lower. While autologous treatments are considered a safer alternative, in some rare circumstances serious, unwanted side effects have occurred.
In the United States it’s legal to harvest stem cells and reintroduce them back into the donor patient; however, it is illegal to culture, process and activate those same cells before injecting them back into the donor patient. Autologous Immune Enhancement Therapy (AIET) involves culturing the cells and because of this, it is illegal in the United States. Allogeneic therapies which don’t involve this process are legal.
In clinical trials, PrimiCell was shown to increase the release of the primitive cells in the blood stream by more than 117% within two weeks, and more than 268% within four weeks of taking the recommended dosage with no negative side effects.